User profiles for Juan M. Vidal
J. VidalProfesor de Construcciones Navales (UCA) Verified email at uca.es Cited by 1966 |
[HTML][HTML] Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types
Background We hypothesized that the abundance of PD1 mRNA in tumor samples might
explain the differences in overall response rates (ORR) observed following anti-PD1 …
explain the differences in overall response rates (ORR) observed following anti-PD1 …
[HTML][HTML] Risk factors for COVID-19 mortality: The effect of convalescent plasma administration
…, PM Carrera Ramos, L Munoz, SA Pesci, JM Vidal… - PLoS …, 2021 - journals.plos.org
Background Convalescent plasma, widely utilized in viral infections that induce neutralizing
antibodies, has been proposed for COVID-19, and preliminary evidence shows that it might …
antibodies, has been proposed for COVID-19, and preliminary evidence shows that it might …
Timing of convalescent plasma administration and 28-day mortality in COVID-19 pneumonia
…, SA Pesci, JM Vidal… - Journal of …, 2022 - journals.sagepub.com
This is a multicenter cohort study including consecutive, hospitalized patients ≥18 years, with
moderate to severe COVID-19, carried out to evaluate the relationship between the timing …
moderate to severe COVID-19, carried out to evaluate the relationship between the timing …
Prognostic impact of atrial fibrillation progression in a community study: AFBAR Study (Atrial Fibrillation in the Barbanza Area Study)
…, F Otero-Raviña, M Lado, A Vizcaya, JM Vidal… - International journal of …, 2011 - Elsevier
INTRODUCTION: The aim of the study is to describe the natural history of an unselected
population of patients with atrial fibrillation (AF) currently attending primary care services in a …
population of patients with atrial fibrillation (AF) currently attending primary care services in a …
SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer
New treatment strategies such as immune checkpoint inhibitors and oncolytic viruses are
opening new possibilities in cancer therapy. Preliminary results in melanoma and other tumors …
opening new possibilities in cancer therapy. Preliminary results in melanoma and other tumors …
Effect of convalescent plasma on mortality in patients with COVID-19 pneumonia
…, PM Carrera Ramos, L Muñoz, SA Pesci, JM Vidal… - medRxiv, 2020 - medrxiv.org
Background Convalescent plasma, widely utilized in viral infections that induce neutralizing
antibodies, has been proposed for COVID-19, and preliminary evidence shows that it might …
antibodies, has been proposed for COVID-19, and preliminary evidence shows that it might …
[HTML][HTML] Why Are the High Frequency Structures of the Sea Surface Temperature in the Brazil–Malvinas Confluence Area Difficult to Predict? An Explanation Based on …
JJ Alonso, JM Vidal, E Blázquez - Journal of Marine Science and …, 2023 - mdpi.com
The Brazil–Malvinas Confluence (BMC) is one of the most complex oceanic areas in the
Earth’s oceans and the prediction of high frequency structures tends to fail. The authors studied …
Earth’s oceans and the prediction of high frequency structures tends to fail. The authors studied …
On the outflow of Lake Maracaibo, Venezuela
EB Gómez, JJ Alonso, JM Vidal - Regional Studies in Marine Science, 2017 - Elsevier
Lake Maracaibo, an important wet coastal area located in the Caribbean Sea, is connected
to the Gulf of Venezuela by a narrow, shallow channel known as Barra de Maracaibo. The …
to the Gulf of Venezuela by a narrow, shallow channel known as Barra de Maracaibo. The …
[HTML][HTML] Low-cost methodology to study the settlement of solid blocks on sandy bottoms
A low-cost methodology is proposed to provide settlement data for solid blocks in order to
improve the design of future coastal structures. Two methods were used to determine how far …
improve the design of future coastal structures. Two methods were used to determine how far …
Abstract OT1-01-01: SOLTI-1503 PROMETEO: Combination of talimogene laherparepvec (T-VEC) with atezolizumab in patients with residual breast cancer after …
…, M Oliveira, JM Cejalvo, L de la Cruz, M Juan… - Cancer Research, 2020 - AACR
Background: New strategies as immune blockade inhibitors and oncolytic viruses are
opening new possibilities in cancer therapy. Preliminary results in melanoma showed that the …
opening new possibilities in cancer therapy. Preliminary results in melanoma showed that the …